NCT03176290View on ClinicalTrials.gov

Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Liver Transplantation
Interventions
DIAGNOSTIC_TEST

Fibro-α score = (1.35 (numeric constant) +AFP (IU ml-1) × 0.009584 + aspartate aminotransferase (AST)/alanine aminotransferase(ALT) × 0.243 - platelet count (×109 l-1) × 0.001624).

Radiological investigations included Abdominal Doppler ultrasound, Magnetic Resonance Elastography(within 3 months of liver biopsy) and fibroscan.

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03176290 - Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation | Biotech Hunter | Biotech Hunter